![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NOVARTIS TO ACQUIRE BRISTOL-MYERS OTC PORTFOLIO
NOVARTIS TO ACQUIRE BRISTOL-MYERS OTC PORTFOLIO
Swiss drugmaker Novartis (NOVN.VX: Quote, Profile, Research) said on Thursday it will pay $660 million for the rights to produce and market Bristol-Myers Squibb Co.'s (BMY.N: Quote, Profile, Research) North American over-the-counter products, including the painkiller Excedrin. Other brands included in the deal are Keri, No-Doz, and Comtrex, Novartis said in a statement.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct